{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T00:40:17Z","timestamp":1794616817095,"version":"4.9.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["20-BR-03-02"],"award-info":[{"award-number":["20-BR-03-02"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["20-BR-03-02"],"award-info":[{"award-number":["20-BR-03-02"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["20-BR-03-02"],"award-info":[{"award-number":["20-BR-03-02"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["20-BR-03-02"],"award-info":[{"award-number":["20-BR-03-02"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["20-BR-03-02"],"award-info":[{"award-number":["20-BR-03-02"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["20-BR-03-02"],"award-info":[{"award-number":["20-BR-03-02"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["20-BR-03-02"],"award-info":[{"award-number":["20-BR-03-02"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["20-BR-03-02"],"award-info":[{"award-number":["20-BR-03-02"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["20-BR-03-02"],"award-info":[{"award-number":["20-BR-03-02"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["20-BR-03-02"],"award-info":[{"award-number":["20-BR-03-02"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Korean government, MSIT","award":["NRF-2014M3C7A1046041"],"award-info":[{"award-number":["NRF-2014M3C7A1046041"]}]},{"name":"Korean government, MSIT","award":["NRF-2014M3C7A1046041"],"award-info":[{"award-number":["NRF-2014M3C7A1046041"]}]},{"name":"Korean government, MSIT","award":["NRF-2014M3C7A1046041"],"award-info":[{"award-number":["NRF-2014M3C7A1046041"]}]},{"name":"Korean government, MSIT","award":["NRF-2014M3C7A1046041"],"award-info":[{"award-number":["NRF-2014M3C7A1046041"]}]},{"name":"Korean government, MSIT","award":["NRF-2014M3C7A1046041"],"award-info":[{"award-number":["NRF-2014M3C7A1046041"]}]},{"name":"Korean government, MSIT","award":["NRF-2014M3C7A1046041"],"award-info":[{"award-number":["NRF-2014M3C7A1046041"]}]},{"name":"Korean government, MSIT","award":["NRF-2014M3C7A1046041"],"award-info":[{"award-number":["NRF-2014M3C7A1046041"]}]},{"name":"Korean government, MSIT","award":["NRF-2014M3C7A1046041"],"award-info":[{"award-number":["NRF-2014M3C7A1046041"]}]},{"name":"Korean government, MSIT","award":["NRF-2014M3C7A1046041"],"award-info":[{"award-number":["NRF-2014M3C7A1046041"]}]},{"name":"Korean government, MSIT","award":["NRF-2014M3C7A1046041"],"award-info":[{"award-number":["NRF-2014M3C7A1046041"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Alzheimer disease (AD) is a leading cause of dementia that has gained prominence in our aging society. Yet, the complexity of diagnosing AD and measuring its invasiveness poses an obstacle. To this end, blood-based biomarkers could mitigate the inconveniences that impede an accurate diagnosis. We developed models to diagnose AD and measure the severity of neurocognitive impairment using blood protein biomarkers. Multiple reaction monitoring\u2013mass spectrometry, a highly selective and sensitive approach for quantifying targeted proteins in samples, was used to analyze blood samples from 4 AD groups: cognitive normal control, asymptomatic AD, prodromal AD), and AD dementia. Multimarker models were developed using 10 protein biomarkers and apolipoprotein E genotypes for amyloid beta and 10 biomarkers with Korean Mini-Mental Status Examination (K-MMSE) score for predicting Alzheimer disease progression. The accuracies for the AD classification model and AD progression monitoring model were 84.9% (95% CI 82.8 to 87.0) and 79.1% (95% CI 77.8 to 80.5), respectively. The models were more accurate in diagnosing AD, compared with single APOE genotypes and the K-MMSE score. Our study demonstrates the possibility of predicting AD with high accuracy by blood biomarker analysis as an alternative method of screening for AD.<\/jats:p>","DOI":"10.1038\/s41598-022-05384-8","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T06:03:57Z","timestamp":1643004237000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Plasma protein biomarker model for screening Alzheimer disease using multiple reaction monitoring-mass spectrometry"],"prefix":"10.1038","volume":"12","author":[{"given":"Yeongshin","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaenyeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minsoo","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihyeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Injoon","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu Yeong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoowon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeong C.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngsoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,24]]},"reference":[{"key":"5384_CR1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239\u2013259. https:\/\/doi.org\/10.1007\/BF00308809 (1991).","journal-title":"Acta Neuropathol."},{"key":"5384_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12068","author":"Alzheimer's disease facts and figures","year":"2020","unstructured":"Alzheimer\u2019s disease facts and figures. Alzheimers Dement. https:\/\/doi.org\/10.1002\/alz.12068 (2020).","journal-title":"Alzheimers Dement."},{"key":"5384_CR3","doi-asserted-by":"publisher","first-page":"330","DOI":"10.2174\/156720511795745348","volume":"8","author":"I Driscoll","year":"2011","unstructured":"Driscoll, I. & Troncoso, J. Asymptomatic Alzheimer\u2019s disease: A prodrome or a state of resilience?. Curr. Alzheimer Res. 8, 330\u2013335 (2011).","journal-title":"Curr. Alzheimer Res."},{"key":"5384_CR4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann, G. M. et al. The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7, 263\u2013269. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.005 (2011).","journal-title":"Alzheimers Dement"},{"key":"5384_CR5","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann, G. et al. Clinical diagnosis of Alzheimer\u2019s disease: Report of the NINCDS-ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology 34, 939\u2013939 (1984).","journal-title":"Neurology"},{"key":"5384_CR6","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert, M. S. et al. The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7, 270\u2013279. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.008 (2011).","journal-title":"Alzheimers Dement"},{"key":"5384_CR7","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1001\/jamainternmed.2015.2152","volume":"175","author":"KK Tsoi","year":"2015","unstructured":"Tsoi, K. K., Chan, J. Y., Hirai, H. W., Wong, S. Y. & Kwok, T. C. Cognitive tests to detect dementia: A systematic review and meta-analysis. JAMA Int. Med. 175, 1450\u20131458. https:\/\/doi.org\/10.1001\/jamainternmed.2015.2152 (2015).","journal-title":"JAMA Int. Med."},{"key":"5384_CR8","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.nrleng.2013.07.005","volume":"29","author":"C Carnero-Pardo","year":"2014","unstructured":"Carnero-Pardo, C. Should the Mini-Mental State Examination be retired?. Neurolog\u00eda (English Edition) 29, 473\u2013481. https:\/\/doi.org\/10.1016\/j.nrleng.2013.07.005 (2014).","journal-title":"Neurolog\u00eda (English Edition)"},{"key":"5384_CR9","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/s1474-4422(03)00530-1","volume":"2","author":"K Blennow","year":"2003","unstructured":"Blennow, K. & Hampel, H. CSF markers for incipient Alzheimer\u2019s disease. Lancet Neurol. 2, 605\u2013613. https:\/\/doi.org\/10.1016\/s1474-4422(03)00530-1 (2003).","journal-title":"Lancet Neurol."},{"key":"5384_CR10","doi-asserted-by":"publisher","first-page":"101066","DOI":"10.1016\/j.arr.2020.101066","volume":"60","author":"SH Rehiman","year":"2020","unstructured":"Rehiman, S. H. et al. Proteomics as a reliable approach for discovery of blood-based Alzheimer\u2019s disease biomarkers: A systematic review and meta-analysis. Ageing Res. Rev. 60, 101066. https:\/\/doi.org\/10.1016\/j.arr.2020.101066 (2020).","journal-title":"Ageing Res. Rev."},{"key":"5384_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney, M. D., Sagare, A. P. & Zlokovic, B. V. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat. Rev. Neurol. 14, 133\u2013150. https:\/\/doi.org\/10.1038\/nrneurol.2017.188 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"5384_CR12","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1373\/clinchem.2009.130518","volume":"56","author":"C Mulder","year":"2010","unstructured":"Mulder, C. et al. Amyloid-beta(1\u201342), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease. Clin. Chem. 56, 248\u2013253. https:\/\/doi.org\/10.1373\/clinchem.2009.130518 (2010).","journal-title":"Clin. Chem."},{"key":"5384_CR13","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1001\/archneur.57.1.100","volume":"57","author":"PD Mehta","year":"2000","unstructured":"Mehta, P. D. et al. Plasma and cerebrospinal fluid levels of amyloid \u03b2 proteins 1\u201340 and 1\u201342 in Alzheimer disease. Arch. Neurol. 57, 100\u2013105. https:\/\/doi.org\/10.1001\/archneur.57.1.100 (2000).","journal-title":"Arch. Neurol."},{"key":"5384_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13024-017-0206-8","volume":"12","author":"H Tatebe","year":"2017","unstructured":"Tatebe, H. et al. Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: Pilot case-control studies including patients with Alzheimer\u2019s disease and down syndrome. Mol Neurodegener 12, 63. https:\/\/doi.org\/10.1186\/s13024-017-0206-8 (2017).","journal-title":"Mol Neurodegener"},{"key":"5384_CR15","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1007\/s00018-007-7220-x","volume":"64","author":"F Hernandez","year":"2007","unstructured":"Hernandez, F. & Avila, J. Tauopathies. Cell. Mol. Life Sci. 64, 2219\u20132233. https:\/\/doi.org\/10.1007\/s00018-007-7220-x (2007).","journal-title":"Cell. Mol. Life Sci."},{"key":"5384_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1602\/neurorx.1.2.213","volume":"1","author":"K Blennow","year":"2004","unstructured":"Blennow, K. Cerebrospinal fluid protein biomarkers for Alzheimer\u2019s disease. NeuroRx 1, 213\u2013225. https:\/\/doi.org\/10.1602\/neurorx.1.2.213 (2004).","journal-title":"NeuroRx"},{"key":"5384_CR17","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/aps.2017.28","volume":"38","author":"GF Chen","year":"2017","unstructured":"Chen, G. F. et al. Amyloid beta: Structure, biology and structure-based therapeutic development. Acta Pharmacol. Sin. 38, 1205\u20131235. https:\/\/doi.org\/10.1038\/aps.2017.28 (2017).","journal-title":"Acta Pharmacol. Sin."},{"key":"5384_CR18","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/ana.25123","volume":"83","author":"PA Boyle","year":"2018","unstructured":"Boyle, P. A. et al. Person-specific contribution of neuropathologies to cognitive loss in old age. Ann. Neurol. 83, 74\u201383. https:\/\/doi.org\/10.1002\/ana.25123 (2018).","journal-title":"Ann. Neurol."},{"key":"5384_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/nmeth.2309","volume":"10","author":"MA Gillette","year":"2013","unstructured":"Gillette, M. A. & Carr, S. A. Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry. Nat. Methods. 10, 28\u201334. https:\/\/doi.org\/10.1038\/nmeth.2309 (2013).","journal-title":"Nat. Methods."},{"key":"5384_CR20","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/nbt.1900","volume":"29","author":"JR Whiteaker","year":"2011","unstructured":"Whiteaker, J. R. et al. A targeted proteomics-based pipeline for verification of biomarkers in plasma. Nat. Biotechnol. 29, 625\u2013634. https:\/\/doi.org\/10.1038\/nbt.1900 (2011).","journal-title":"Nat. Biotechnol."},{"key":"5384_CR21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/nmeth.2763","volume":"11","author":"JJ Kennedy","year":"2014","unstructured":"Kennedy, J. J. et al. Demonstrating the feasibility of large-scale development of standardized assays to quantify human proteins. Nat. Methods 11, 149\u2013155. https:\/\/doi.org\/10.1038\/nmeth.2763 (2014).","journal-title":"Nat. Methods"},{"key":"5384_CR22","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41591-020-0815-6","volume":"26","author":"ECB Johnson","year":"2020","unstructured":"Johnson, E. C. B. et al. Large-scale proteomic analysis of Alzheimer\u2019s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat. Med. 26, 769\u2013780. https:\/\/doi.org\/10.1038\/s41591-020-0815-6 (2020).","journal-title":"Nat. Med."},{"key":"5384_CR23","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1002\/pmic.201100568","volume":"12","author":"D Domanski","year":"2012","unstructured":"Domanski, D. et al. MRM-based multiplexed quantitation of 67 putative cardiovascular disease biomarkers in human plasma. Proteomics 12, 1222\u20131243. https:\/\/doi.org\/10.1002\/pmic.201100568 (2012).","journal-title":"Proteomics"},{"key":"5384_CR24","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/s0140-6736(15)01124-1","volume":"388","author":"P Scheltens","year":"2016","unstructured":"Scheltens, P. et al. Alzheimer\u2019s disease. Lancet 388, 505\u2013517. https:\/\/doi.org\/10.1016\/s0140-6736(15)01124-1 (2016).","journal-title":"Lancet"},{"key":"5384_CR25","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer, L. A. et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: A meta-analysis. JAMA 278, 1349\u20131356 (1997).","journal-title":"JAMA"},{"key":"5384_CR26","doi-asserted-by":"publisher","first-page":"5281","DOI":"10.1046\/j.1532-5415.5153.x","volume":"51","author":"BP Leifer","year":"2003","unstructured":"Leifer, B. P. Early diagnosis of Alzheimer\u2019s disease: Clinical and economic benefits. J. Am. Geriatr. Soc. 51, 5281\u20135288. https:\/\/doi.org\/10.1046\/j.1532-5415.5153.x (2003).","journal-title":"J. Am. Geriatr. Soc."},{"key":"5384_CR27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fnagi.2010.00008","volume":"2","author":"TA Bayer","year":"2010","unstructured":"Bayer, T. A. & Wirths, O. Intracellular accumulation of amyloid-Beta\u2014a predictor for synaptic dysfunction and neuron loss in Alzheimer\u2019s disease. Front. Aging Neurosci. 2, 8. https:\/\/doi.org\/10.3389\/fnagi.2010.00008 (2010).","journal-title":"Front. Aging Neurosci."},{"key":"5384_CR28","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/nm.3898","volume":"21","author":"LK Smith","year":"2015","unstructured":"Smith, L. K. et al. beta2-microglobulin is a systemic pro-aging factor that impairs cognitive function and neurogenesis. Nat. Med. 21, 932\u2013937. https:\/\/doi.org\/10.1038\/nm.3898 (2015).","journal-title":"Nat. Med."},{"key":"5384_CR29","doi-asserted-by":"publisher","first-page":"15936","DOI":"10.1038\/s41598-019-52324-0","volume":"9","author":"S Forner","year":"2019","unstructured":"Forner, S. et al. Intra- and extracellular beta-amyloid overexpression via adeno-associated virus-mediated gene transfer impairs memory and synaptic plasticity in the hippocampus. Sci. Rep. 9, 15936. https:\/\/doi.org\/10.1038\/s41598-019-52324-0 (2019).","journal-title":"Sci. Rep."},{"key":"5384_CR30","doi-asserted-by":"publisher","unstructured":"Provensi, G. et al. A new kid on the block? Carbonic anhydrases as possible new targets in Alzheimer's disease. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms20194724 (2019).","DOI":"10.3390\/ijms20194724"},{"key":"5384_CR31","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/MOH.0000000000000368","volume":"24","author":"HJ Ahn","year":"2017","unstructured":"Ahn, H. J., Chen, Z. L., Zamolodchikov, D., Norris, E. H. & Strickland, S. Interactions of beta-amyloid peptide with fibrinogen and coagulation factor XII may contribute to Alzheimer\u2019s disease. Curr. Opin. Hematol. 24, 427\u2013431. https:\/\/doi.org\/10.1097\/MOH.0000000000000368 (2017).","journal-title":"Curr. Opin. Hematol."},{"key":"5384_CR32","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","volume":"21","author":"H Akiyama","year":"2000","unstructured":"Akiyama, H. et al. Inflammation and Alzheimer\u2019s disease. Neurobiol. Aging 21, 383\u2013421 (2000).","journal-title":"Neurobiol. Aging"},{"key":"5384_CR33","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1179\/016164106X110454","volume":"28","author":"L Gerardino","year":"2006","unstructured":"Gerardino, L. et al. Coagulation factor XIII Val34Leu gene polymorphism and Alzheimer\u2019s disease. Neurol. Res. 28, 807\u2013809. https:\/\/doi.org\/10.1179\/016164106X110454 (2006).","journal-title":"Neurol. Res."},{"key":"5384_CR34","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3233\/JAD-200110","volume":"76","author":"M Chen","year":"2020","unstructured":"Chen, M. & Xia, W. Proteomic profiling of plasma and brain tissue from Alzheimer\u2019s disease patients reveals candidate network of plasma biomarkers. J. Alzheimers Dis. 76, 349\u2013368. https:\/\/doi.org\/10.3233\/JAD-200110 (2020).","journal-title":"J. Alzheimers Dis."},{"key":"5384_CR35","doi-asserted-by":"crossref","unstructured":"Fischer, P., G\u00f6tz, M. E., Danielczyk, W., Gsell, W. & Riederer P. Blood transferrin and ferritin in Alzheimer's disease. Life Sciences 60, 2273\u20132278 (1997).","DOI":"10.1016\/S0024-3205(97)00282-8"},{"key":"5384_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/157015909787602805","volume":"7","author":"MV Kolev","year":"2009","unstructured":"Kolev, M. V., Ruseva, M. M., Harris, C. L., Morgan, B. P. & Donev, R. M. Implication of complement system and its regulators in Alzheimer\u2019s disease. Curr. Neuropharmacol. 7, 1\u20138 (2009).","journal-title":"Curr. Neuropharmacol."},{"key":"5384_CR37","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.ajpath.2010.11.057","volume":"178","author":"Y Cui","year":"2011","unstructured":"Cui, Y., Huang, M., He, Y., Zhang, S. & Luo, Y. Genetic ablation of apolipoprotein A-IV accelerates Alzheimer\u2019s disease pathogenesis in a mouse model. Am J Pathol 178, 1298\u20131308. https:\/\/doi.org\/10.1016\/j.ajpath.2010.11.057 (2011).","journal-title":"Am J Pathol"},{"key":"5384_CR38","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/0304-3940(92)90531-B","volume":"134","author":"Y Namba","year":"1992","unstructured":"Namba, Y., Tsuchiya, H. & Ikeda, K. Apolipoprotein B immunoreactivity in senile plaque and vascular amyloids and neurofibrillary tangles in the brains of patients with Alzheimer\u2019s disease. Neurosci. Lett. 134, 264\u2013266 (1992).","journal-title":"Neurosci. Lett."},{"key":"5384_CR39","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3233\/JAD-132102","volume":"40","author":"H Yang","year":"2014","unstructured":"Yang, H. et al. Prognostic polypeptide blood plasma biomarkers of Alzheimer\u2019s disease progression. J. Alzheimers Dis. 40, 659\u2013666 (2014).","journal-title":"J. Alzheimers Dis."},{"key":"5384_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2011.01.008","volume":"130","author":"BK Yoo","year":"2011","unstructured":"Yoo, B. K. et al. Astrocyte elevated gene-1 (AEG-1): A multifunctional regulator of normal and abnormal physiology. Pharmacol. Ther. 130, 1\u20138. https:\/\/doi.org\/10.1016\/j.pharmthera.2011.01.008 (2011).","journal-title":"Pharmacol. Ther."},{"key":"5384_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176419","author":"JY Kim","year":"2020","unstructured":"Kim, J. Y., Barua, S., Jeong, Y. J. & Lee, J. E. Adiponectin: The potential regulator and therapeutic target of obesity and Alzheimer\u2019s disease. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms21176419 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"5384_CR42","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/978-3-319-17344-3_8","volume":"855","author":"M Das","year":"2015","unstructured":"Das, M. & Gursky, O. Amyloid-forming properties of human apolipoproteins: Sequence analyses and structural insights. Adv. Exp. Med. Biol. 855, 175\u2013211. https:\/\/doi.org\/10.1007\/978-3-319-17344-3_8 (2015).","journal-title":"Adv. Exp. Med. Biol."},{"key":"5384_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13041-019-0439-2","volume":"12","author":"J-Y Koh","year":"2019","unstructured":"Koh, J.-Y., Kim, H. N., Hwang, J. J., Kim, Y.-H. & Park, S. E. Lysosomal dysfunction in proteinopathic neurodegenerative disorders: Possible therapeutic roles of cAMP and zinc. Mol. Brain 12, 1\u201311 (2019).","journal-title":"Mol. Brain"},{"key":"5384_CR44","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/s0165-5728(02)00444-7","volume":"135","author":"X Luo","year":"2003","unstructured":"Luo, X., Weber, G. A., Zheng, J., Gendelman, H. E. & Ikezu, T. C1q\u2013calreticulin induced oxidative neurotoxicity: Relevance for the neuropathogenesis of Alzheimer\u2019s disease. J. Neuroimmunol. 135, 62\u201371. https:\/\/doi.org\/10.1016\/s0165-5728(02)00444-7 (2003).","journal-title":"J. Neuroimmunol."},{"key":"5384_CR45","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2019.1424","author":"BJ Hanseeuw","year":"2019","unstructured":"Hanseeuw, B. J. et al. Association of amyloid and tau with cognition in preclinical Alzheimer disease: A longitudinal study. JAMA Neurol. https:\/\/doi.org\/10.1001\/jamaneurol.2019.1424 (2019).","journal-title":"JAMA Neurol."},{"key":"5384_CR46","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrn2194","volume":"8","author":"C Ballatore","year":"2007","unstructured":"Ballatore, C., Lee, V. M. & Trojanowski, J. Q. Tau-mediated neurodegeneration in Alzheimer\u2019s disease and related disorders. Nat Rev Neurosci 8, 663\u2013672. https:\/\/doi.org\/10.1038\/nrn2194 (2007).","journal-title":"Nat Rev Neurosci"},{"key":"5384_CR47","volume-title":"Seoul Neuropsychological Screening Battery (SNSB)","author":"Y Kang","year":"2012","unstructured":"Kang, Y., Jang, S. & Na, D. L. Seoul Neuropsychological Screening Battery (SNSB) (Human Brain Research and Consulting Co., Seoul, 2012)."},{"key":"5384_CR48","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/wnl.43.11.2412-a","volume":"43","author":"JC Morris","year":"1993","unstructured":"Morris, J. C. The clinical dementia rating (CDR): Current version and scoring rules. Neurology 43, 2412\u20132414. https:\/\/doi.org\/10.1212\/wnl.43.11.2412-a (1993).","journal-title":"Neurology"},{"key":"5384_CR49","first-page":"300","volume":"15","author":"Y Kang","year":"1997","unstructured":"Kang, Y., Na, D. L. & Hahn, S. A validity study on the Korean Mini-Mental State Examination (K-MMSE) in dementia patients. J. Korean Neurol. Assoc. 15, 300\u2013308 (1997).","journal-title":"J. Korean Neurol. Assoc."},{"key":"5384_CR50","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/s1474-4422(10)70223-4","volume":"9","author":"B Dubois","year":"2010","unstructured":"Dubois, B. et al. Revising the definition of Alzheimer\u2019s disease: A new lexicon. Lancet Neurol. 9, 1118\u20131127. https:\/\/doi.org\/10.1016\/s1474-4422(10)70223-4 (2010).","journal-title":"Lancet Neurol."},{"key":"5384_CR51","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1007\/s00259-011-1821-1","volume":"38","author":"H Barthel","year":"2011","unstructured":"Barthel, H. et al. Individualized quantification of brain beta-amyloid burden: Results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer\u2019s disease and healthy controls. Eur J Nucl Med Mol Imaging 38, 1702\u20131714. https:\/\/doi.org\/10.1007\/s00259-011-1821-1 (2011).","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5384_CR52","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s10967-010-0514-8","volume":"284","author":"M Patt","year":"2010","unstructured":"Patt, M. et al. Metabolite analysis of [18F]Florbetaben (BAY 94\u20139172) in human subjects: A substudy within a proof of mechanism clinical trial. J. Radioanal. Nucl. Chem. 284, 557\u2013562. https:\/\/doi.org\/10.1007\/s10967-010-0514-8 (2010).","journal-title":"J. Radioanal. Nucl. Chem."},{"key":"5384_CR53","doi-asserted-by":"publisher","first-page":"e0162930","DOI":"10.1371\/journal.pone.0162930","volume":"11","author":"YH Jee","year":"2016","unstructured":"Jee, Y. H., Lee, S. J., Jung, K. J. & Jee, S. H. Alcohol intake and serum glucose levels from the perspective of a mendelian randomization design: The KCPS-II Biobank. PLoS ONE 11, e0162930. https:\/\/doi.org\/10.1371\/journal.pone.0162930 (2016).","journal-title":"PLoS ONE"},{"key":"5384_CR54","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1373\/clinchem.2009.138420","volume":"56","author":"SE Abbatiello","year":"2010","unstructured":"Abbatiello, S. E., Mani, D. R., Keshishian, H. & Carr, S. A. Automated detection of inaccurate and imprecise transitions in peptide quantification by multiple reaction monitoring mass spectrometry. Clin. Chem. 56, 291\u2013305. https:\/\/doi.org\/10.1373\/clinchem.2009.138420 (2010).","journal-title":"Clin. Chem."},{"key":"5384_CR55","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1002\/pmic.201600044","volume":"16","author":"D Pascovici","year":"2016","unstructured":"Pascovici, D., Handler, D. C., Wu, J. X. & Haynes, P. A. Multiple testing corrections in quantitative proteomics: A useful but blunt tool. Proteomics 16, 2448\u20132453. https:\/\/doi.org\/10.1002\/pmic.201600044 (2016).","journal-title":"Proteomics"},{"key":"5384_CR56","doi-asserted-by":"publisher","first-page":"e0224365","DOI":"10.1371\/journal.pone.0224365","volume":"14","author":"A Vabalas","year":"2019","unstructured":"Vabalas, A., Gowen, E., Poliakoff, E. & Casson, A. J. Machine learning algorithm validation with a limited sample size. PLoS ONE 14, e0224365. https:\/\/doi.org\/10.1371\/journal.pone.0224365 (2019).","journal-title":"PLoS ONE"},{"key":"5384_CR57","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1093\/bioinformatics\/btaa046","volume":"36","author":"S Parvandeh","year":"2020","unstructured":"Parvandeh, S., Yeh, H. W., Paulus, M. P. & McKinney, B. A. Consensus features nested cross-validation. Bioinformatics 36, 3093\u20133098. https:\/\/doi.org\/10.1093\/bioinformatics\/btaa046 (2020).","journal-title":"Bioinformatics"},{"key":"5384_CR58","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W da Huang","year":"2009","unstructured":"da Huang, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44\u201357. https:\/\/doi.org\/10.1038\/nprot.2008.211 (2009).","journal-title":"Nat. Protoc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05384-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05384-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05384-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T16:20:17Z","timestamp":1669306817000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05384-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,24]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["5384"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-05384-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,24]]},"assertion":[{"value":"5 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1282"}}